|
    ABMD U.S.: Nasdaq

    Abiomed Inc.

    ABMDUS
    After Hours
    Back To Top
    Last Updated: Jul 23, 2021 4:47 p.m. EDT Delayed quote

    $ 328.52

    0.00 0.00%
    After Hours Volume: 3.57K
    Close Chg Chg %
    $328.52 4.98 1.54%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 148.02K 65 Day Avg: 260.37K
    57% vs Avg
    323.84 Day Range 328.84
    242.73 52 Week Range 387.40

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABMD Overview

    Performance

    5 Day
    • 3.31%
    1 Month
    • 5.45%
    3 Month
    • -6.41%
    YTD
    • 1.33%
    1 Year
    • 12.15%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 11 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    Read full story

    Abiomed Inc. stock rises Friday, outperforms market

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock underperforms Wednesday when compared to competitors

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock outperforms market despite losses on the day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock falls Thursday, underperforms market

    Read full story

    Abiomed Inc. stock falls Wednesday, underperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock falls Monday, underperforms market

    Read full story

    Abiomed Inc. stock falls Friday, underperforms market

    Read full story

    Abiomed Inc. stock falls Thursday, underperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock rises Tuesday, outperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock rises Thursday, still underperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock underperforms Friday when compared to competitors

    • Other News
    • Press Releases

    Could This Recently IPOed Medical Device Maker Make You Rich?

    on Motley Fool

    Abiomed's (ABMD) Impella RP With SmartAssist Gets FDA Nod

    on Zacks.com

    Abiomed (ABMD) Enters Overbought Territory

    on Zacks.com

    Friday’s Top Analyst Upgrades and Downgrades: Alaska Air, Biogen, Cirrus Logic, Lennar, Match, Occidental and United Airlines

    on 247WallSt.com

    Analysts Are Bullish on Top Healthcare Stocks: Abiomed (ABMD), Vertex Pharmaceuticals (VRTX)

    on SmarterAnalyst

    Abiomed's (ABMD) preCARDIA Buyout Expands Its Product Portfolio

    on Zacks.com

    Avoid the Dogecoin Crash by Buying These 2 Growth Stocks Instead

    on Motley Fool

    New Strong Sell Stocks for May 4th

    on Zacks.com

    Abiomed to Shareholders: Patience Please, Growth Is On The Way.

    on Motley Fool

    The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts

    on Motley Fool

    BTIG Sticks to Their Hold Rating for Abiomed (ABMD)

    on SmarterAnalyst

    ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4

    on Zacks.com

    Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript

    on Motley Fool

    Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates

    on Zacks.com

    Analysts Conflicted on These Healthcare Names: Abiomed (ABMD), Amgen (AMGN) and Stryker (SYK)

    on SmarterAnalyst

    ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards?

    on Zacks.com

    Abiomed (ABMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    on Zacks.com

    3 Overlooked Healthcare Stocks to Buy Right Now

    on Motley Fool

    Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction

    on Motley Fool

    Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath

    on Motley Fool

    Abiomed Inc.

    ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

    Competitors

    Name Chg % Market Cap
    Medtronic PLC 1.13% $172.75B
    Stryker Corp. 1.38% $98.96B
    Boston Scientific Corp. 1.31% $62.69B
    Teleflex Inc. 1.21% $18.6B
    Boston Scientific Corp. 5.5% Pfd. Series A 1.32%
    Competitor Data Provided ByCapital Cube Logo